logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 [see all tables in this series...]

Part (v) Percentage distribution of new inpatient clients by age at first use for each primary drug

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opiates4.941.631.211.65.82.51.21.422.22706135
Cocaine541.725.812.39.23.61.40.822.535731
Stimulants14.358.817.652.50.80.70.319.1116683
Hypnotics and sedatives8.421.815.712.811.37.66.715.729.934458
Hallucinogens1658.72041.300018.5758
Volatile substances54.239.45.60.8000015.72498
Cannabis 30.346.211.85.13.41.90.70.618.7166294
Other substances 12.53513.811.357.53.811.325.88070
Total15.244.821.58.44.82.31.31.820.96639487

Notes:

 Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY, LV, AT, RO, SK, FI, SE, TR. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-108 on distribution by country and 'General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — Table TDI — outpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008